Somatulina Autogel

Somatuline Autogel is a prescription medication containing lanreotide, used for hormone-related conditions like acromegaly and neuroendocrine tumors. It belongs to the somatostatin analog class and is administered via subcutaneous injection. This overview covers its uses, effects, and safety considerations.

Somatuline Autogel (lanreotide) is primarily used to treat acromegaly, a condition caused by excessive growth hormone production. It is also prescribed for neuroendocrine tumors, including gastroenteropancreatic neuroendocrine tumors (GEP-NETs), to manage symptoms and slow tumor growth. The medication works by reducing hormone levels in the body.

Lanreotide helps regulate hormone levels, which may reduce symptoms such as headaches, joint pain, and excessive sweating in acromegaly patients. For neuroendocrine tumor patients, it can help control symptoms like flushing and diarrhea. The effects vary by individual and condition being treated.

Store Somatuline Autogel in a refrigerator until ready for use. Keep the medication away from light and heat. Always follow the handling instructions provided with the product. If you experience irritation at the injection site, consult a healthcare provider. Do not use if the solution is discolored or contains particles.

Lanreotide may interact with medications that affect heart rhythm, such as antiarrhythmics. Caution is advised when combining it with drugs that alter gastrointestinal motility. Always inform your healthcare provider about all medications you are taking. Monitor for changes in blood sugar levels, as lanreotide may affect glucose metabolism.